Investing enterprise:Yuan He pharmaceutical limited by Share Ltd

Brand name/commodity name:Five tower/Anlibo

Investing area:China

Packaging:Aluminum-plastic

Drug category：Western medicine

Approved number:H20060811

Specifications:

150mg:12.5mg/capsule*7capsules/box

150mg:12.5mg/capsule*10capsules/box

150mg:12.5mg/capsule*14capsules/box

150mg:12.5mg/capsule*20capsules/box

Component:

150mg irbesartan and 12.5mg hydrochlorothiazide per capsule

Usage and dosage:once a day,one capsule a day

Product property:

A new generation ideal first-line antihypertensive drugs:for the primary hypertension and the patients who can’t control the blood pressure only with irbesartan or hydrochlothiazide.

Product supplement:

1.better compliance

2.offset adverse reactions by each other

3.easily control the blood pressure to nomal

4.much reduction in blood pressure

5.lower it faster,especially SBP

6.a long-term effect,hardly produce resistance

7.It also have good effect to high-risk patients

8.category B in health insurance,exclusive dosage form

9.good profit,large space,long-term product

10.Some cities have it entered the agricultual cooperative service or based medicine directory.

11.Strong effect,stable,lasting,security,convenient,and we win the bids all over the county.

Requirements for agents；

1.the determination of long-term cooperation

2.a strong sense of responsibility and confidence

3.perfect sales network

4.a certain economic power and good business reputation

5.rich experiences in the operation of the maket,stronger ability of the maket development

In addition,we can provide product information and academic lectures.

Contact information:

Tel:0471-3603940

Pass really:0471-3601928

Mobile phone:13848175986

Contact person:Wang Jinye

Net address:http://www.yuanheyaoye.com

E-mail:113768271@qq.com

Post code:010080

Address:

Jinchuan economic and technological development zone in  Huhot